| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 3.27 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Introdução:A fibromialgia é uma doença caracterizada por dor generalizada, fadiga, distúrbios de sono e problemas psicológicos e de cognição. A doença afeta maioritariamente o sexo feminino, na meia idade, sendo a sua prevalência de 1,7% em Portugal. Atualmente não existe cura e o tratamentoda doença é realizado com base nos sintomas, sendo constituído por tratamento farmacológico e não farmacológico. A fibromialgia é de especial relevânciano quotidianodo doente,e pode afetar a sua qualidade de vida negativamente. Objetivos:Caracterizar a farmacoterapia do doente português com fibromialgia, analisandoa sua satisfação no que toca à medicação; e avaliar o impacto destana condição de saúde e capacidade funcionaldo doente. Metodologia: Foi realizado um estudo observacional, onde foi aplicado um questionário online, à população portuguesa, através de associações portuguesas. Foi constituídopor quatro partes: caracterização sociodemográfica; Fibromyalgia Impact Questionnaire; caracterização farmacoterapêutica e o Treatment Satisfaction Questionnaire for Medication. Os dados obtidos foram analisadosestatisticamente e as variáveis foram relacionadasatravés de teste de ANOVA e correlação de Pearson.Resultados: A amostraapresentou um score de 64,89 ±15,92 no Fibromyalgia Impact Questionnaire, que se evidenciou relacionadocom aidade e a zona de residência (p=0,039 e p=0,047respetivamente). Os grupos de fármacosmais comumenteutilizados pelos doentes foram: anti-inflamatórios não esteróides (17,7%) e ansiolíticos(16,9%). Relativamente à satisfação com a medicação, os doentes evidenciaram um score de 67,87 na “Conveniência”, 67,59 nos “Efeitos Adversos”, 45,01 na “Eficácia” e 46,25 na “Satisfação Global”.Esta mostrou-seinfluenciada pelo tempo de diagnóstico, número de medicamentos administradose pela natureza da medicação.Discussão e Conclusão: Os resultados doscore do Fibromyalgia Impact Questionnaireevidenciam quea doença tem um impacto negativo na vida doente, uma vez que o score apresenta um valor superior a 50. Os doentes com fibromialgia tendem a tomar mais que uma medicação, e os gruposfarmacoterapêuticosdosanti-inflamatóriosnão esteróides e ansiolíticos são os mais usados, no entanto são também os menos aconselhados na literatura devido à falta de eficácia e/ou efeitos secundários. Também várias classes de antidepressivos e anticonvulsivantes são grupos usados para o tratamento da fibromialgia, que apesar de eficazes, não representam os grupos de maior consumo. Relativamente à satisfação com a medicação, os valores devem ser avaliados cuidadosamente devido à diversidade do tratamento. A fibromialgia tem um impacto negativo na qualidade de vida, e neste sentido são necessários mais estudos que explorem terapias eficazes na fibromialgia, com efeitos adversos mínimos, de forma a garantir a adesão ao tratamento, melhorandoa qualidade de vida do doente.
Introduction: Fibromyalgia is characterized by widespread pain, fatigue, sleep disturbance, and psychological and cognitive problems. The disease affects mainly females in middle age and has a prevalence of 1,7% in Portugal. The treatment is based on experienced symptoms and consists in pharmacological and non-pharmacological treatment. Fibromyalgia has an important impact onpatient's life and can negatively affect their quality of life. Objectives:Characterize the patient's pharmacotherapy and analysetheir satisfaction with medicationandunderstand if this affectspatient's health condition and functional capacity. Methodology: An observational study was made with the application of an online questionnaireto the Portuguese population, throughportuguese associations. Itwas composed by four parts: sociodemographic characterization; Fibromyalgia Impact Questionnaire; pharmacotherapeutic characterization and the Treatment Satisfaction Questionnaire for MedicationThe data obtained were statistically analysed and the variables were relatedtrough ANOVA and Pearson correlation.Results: The population presented a score of 64,89 ±15,92 in the Fibromyalgia Impact Questionnaire,and this was associated with age and the area of residence (p= 0,039 and p= 0,047). The most common medication among patients werethe non-steroidal anti-inflammatory group (17,7%) and anxiolyticsdrugs(16,9%). Regarding the Treatment Satisfaction Questionnaire, the score was 67,87 for “Convenience”, 67,59 for “Adverse Effects”, 45,01 for “Effectiveness” and 46,25 for “Global Satisfaction”and wasinfluenced by time of diagnosis, number of medications taken and bythe drug classes. Discussion and Conclusion:From the average Fibromyalgia Impact Questionnaire score, it can be observedthat the disease has a negative impact on life, since the score is greater than 50. Patients with fibromyalgia tend to take more than one medication: non-steroidal anti-inflammatory and anxiolytic groups are the most commonly used, however they are also the least advised due to lack of efficacy and/or side effects. In addition,antidepressants and anticonvulsants, despite being recommendin fibromyalgiapatients, they are not very common drugs in this sample. The Treatment Satisfaction values should be carefully evaluated due to the diversity of treatment. Further research is needed to unravel effective therapies that can ameliorating the various symptoms of fibromyalgiawith minimal adverse effects, in order to ensure treatment adherence and further improve patient’s quality of life.
Introduction: Fibromyalgia is characterized by widespread pain, fatigue, sleep disturbance, and psychological and cognitive problems. The disease affects mainly females in middle age and has a prevalence of 1,7% in Portugal. The treatment is based on experienced symptoms and consists in pharmacological and non-pharmacological treatment. Fibromyalgia has an important impact onpatient's life and can negatively affect their quality of life. Objectives:Characterize the patient's pharmacotherapy and analysetheir satisfaction with medicationandunderstand if this affectspatient's health condition and functional capacity. Methodology: An observational study was made with the application of an online questionnaireto the Portuguese population, throughportuguese associations. Itwas composed by four parts: sociodemographic characterization; Fibromyalgia Impact Questionnaire; pharmacotherapeutic characterization and the Treatment Satisfaction Questionnaire for MedicationThe data obtained were statistically analysed and the variables were relatedtrough ANOVA and Pearson correlation.Results: The population presented a score of 64,89 ±15,92 in the Fibromyalgia Impact Questionnaire,and this was associated with age and the area of residence (p= 0,039 and p= 0,047). The most common medication among patients werethe non-steroidal anti-inflammatory group (17,7%) and anxiolyticsdrugs(16,9%). Regarding the Treatment Satisfaction Questionnaire, the score was 67,87 for “Convenience”, 67,59 for “Adverse Effects”, 45,01 for “Effectiveness” and 46,25 for “Global Satisfaction”and wasinfluenced by time of diagnosis, number of medications taken and bythe drug classes. Discussion and Conclusion:From the average Fibromyalgia Impact Questionnaire score, it can be observedthat the disease has a negative impact on life, since the score is greater than 50. Patients with fibromyalgia tend to take more than one medication: non-steroidal anti-inflammatory and anxiolytic groups are the most commonly used, however they are also the least advised due to lack of efficacy and/or side effects. In addition,antidepressants and anticonvulsants, despite being recommendin fibromyalgiapatients, they are not very common drugs in this sample. The Treatment Satisfaction values should be carefully evaluated due to the diversity of treatment. Further research is needed to unravel effective therapies that can ameliorating the various symptoms of fibromyalgiawith minimal adverse effects, in order to ensure treatment adherence and further improve patient’s quality of life.
Description
Keywords
Fibromialgia Dor Crónica Treatment Satisfaction Questionnaire for Medication Fibromyalgia Impact Questionnaire